Near-Infrared Light Brightens Bacterial Disinfection: Recent Progress and Perspectives.
Qinyu HanJun Wei LauThang Cong DoZhijun ZhangBengang XingPublished in: ACS applied bio materials (2020)
Bacterial infection is a universal threat to public health, which not only causes many serious diseases but also exacerbates the condition of the patients of cancer, pandemic diseases, e.g. , COVID-19, and so on. Antibiotic therapy has been used to be an effective way for common bacterial disinfection. However, due to the misuse and abuse of antibiotics, more and more antibiotic-resistant bacteria have emerged as fatal threats to human beings. At present, more than 700,000 patients die every year with bacterial infections because of the lack of effective treatment. It is frustrating that the pace of development of antibiotics lags far behind that of bacterial resistance, with an estimation of 10 million deaths per year from bacterial infections after 2050. Facing such a rigorous challenge, approaches for bacterial disinfection are urgently demanded. The recently developed near-infrared (NIR) light-irradiation-based bacterial disinfection is highly promising to shatter bacterial resistance by employing NIR light-responsive materials as mediums to generate antibacterial factors such as heat, reactive oxygen species (ROS), and so on. This treatment approach is proved to be a potent candidate to accurately realize spatiotemporal control, while effectively eradicating multidrug-resistant bacteria and inhibiting antibiotic resistance. Herein, we summarize the latest progress of NIR light-based bacterial disinfection. Ultimately, current challenges and perspectives in this field are discussed.
Keyphrases
- public health
- drinking water
- multidrug resistant
- reactive oxygen species
- end stage renal disease
- coronavirus disease
- sars cov
- ejection fraction
- newly diagnosed
- endothelial cells
- squamous cell carcinoma
- cell death
- fluorescence imaging
- dna damage
- signaling pathway
- chronic kidney disease
- drug resistant
- drug delivery
- oxidative stress
- young adults
- pseudomonas aeruginosa
- chronic pain
- mesenchymal stem cells
- klebsiella pneumoniae
- papillary thyroid
- replacement therapy
- childhood cancer